Fentanyl
From WikiAnesthesia
Fentanyl
| Trade names |
Actiq, Duragesic, Sublimaze |
|---|---|
| Clinical data | |
| Drug class |
Opioid |
| Uses |
Analgesia |
| Routes of administration |
Buccal, Epidural, Intrathecal, Intravenous, Transdermal |
| Dosage | |
| Pharmacodynamics | |
| Mechanism of action |
μ-opioid agonism |
| Pharmacokinetics | |
| Onset of action |
5 minutes |
| Duration of action |
30-60 minutes |
| Metabolism |
Hepatic (CYP3A4) |
| Redistribution half-life |
6 minutes (initial) 1 hour (slow) |
| Elimination half-life |
16 hours |
| Protein binding |
80-85% |
| Physical and chemical data | |
| Formula |
5 minutes |
| Molar mass |
336.479 g/mol |
| Article quality | |
| Editor rating | |
| User likes | 0 |
Fentanyl is a synthetic, lipophilic phenylpiperidine opioid agonist used for analgesia. It is highly lipophilic leading to fast passage across the blood-brain barrier with a 6.8 minute onset time. Fentanyl will also rapidly redistribute to adipose and fatty tissue leading to a short duration of action.
Uses
- Administration
- IV, IM, transdermal, intranasal, intrathecal, epidural, buccal.
Contraindications
Absolute contraindications
Precautions
Pharmacology
Pharmacodynamics
Mechanism of action
- µ-selective opioid receptor
- Low affinity: delta & kappa opioid receptors
Adverse effects
Pharmacokinetics
- Context Sensitive Half Time
- Infusion or repeated doses lead to prolong duration of action as drug redistributes back from tissue to plasma.
Chemistry and formulation
History
References
- Comer SD, Cahill CM. Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neurosci Biobehav Rev. 2019 Nov;106:49-57.
Top contributors: Chris Rishel and Jashvin Patel